Clinical studies have demonstrated a strong association between metabolic diseases including DM and VGF; therefore, a rewiring of cell–cell interaction in such conditions would ignite mechanistic studies for translational treatment to prevent VGF [43,44]. This evidence concerns the gene VGF and Other metabolic disease.